Search research articles
Contact Us
Filters
Showing results (341-350 of 724) with videos related to
Page
of 73
Sort By:
Deutsche Medizinische Wochenschrift (1946)
|
May 2, 1986
[New methods in the radiotherapy of bronchial carcinoma. Endobronchial small-field irradiation using the iridium-129 high-dose afterloading technic in combination with the neodymium-YAG laser]
H N Macha, J Mai, M Stadler, et al.
European Urology
|
March 14, 2009
A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer
Russell Szmulewitz, Supriya Mohile, Edwin Posadas, et al.
Clinical Genitourinary Cancer
|
February 14, 2009
Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma
Kathryn A Bylow, Michael B Atkins, Edwin M Posadas, et al.
The Journal of Laryngology and Otology
|
May 20, 2020
An intact bony tympanic facial canal does not protect from secondary facial paresis in adult acute otitis media
C Meerwein, S Pazahr, T M Stadler, et al.
The Journal of Chemical Physics
|
October 11, 2023
Signature of functional enzyme dynamics in quasielastic neutron scattering spectra: The case of phosphoglycerate kinase
Abir N Hassani, Luman Haris, Markus Appel, et al.
The Journal of Urology
|
February 11, 2003
Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site
Eric C Kauffman, Victoria L Robinson, Walter M Stadler, et al.
Cancer
|
December 18, 2001
Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies
S Mani, N J Vogelzang, D Bertucci, et al.
Thrombosis Research
|
April 27, 2001
Molecular modifications in factor VIII concentrates produced from different plasma pools
E Saenko, D Josic, M Stadler, et al.
The Prostate
|
October 24, 2008
The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer
David Knight, Amy C Peterson, Brian I Rini, et al.
The Journal of Allergy and Clinical Immunology
|
June 1, 1990
A long-term follow-up study of hyposensitization with immunoblotting
E Jarolim, L K Poulsen, B M Stadler, et al.
Page
of 73
Search research articles
Search
Showing results (341-350 of 724) with videos related to
Sort By:
Page
of 73
Deutsche Medizinische Wochenschrift (1946)
|
May 2, 1986
[New methods in the radiotherapy of bronchial carcinoma. Endobronchial small-field irradiation using the iridium-129 high-dose afterloading technic in combination with the neodymium-YAG laser]
H N Macha, J Mai, M Stadler, et al.
European Urology
|
March 14, 2009
A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer
Russell Szmulewitz, Supriya Mohile, Edwin Posadas, et al.
Clinical Genitourinary Cancer
|
February 14, 2009
Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma
Kathryn A Bylow, Michael B Atkins, Edwin M Posadas, et al.
The Journal of Laryngology and Otology
|
May 20, 2020
An intact bony tympanic facial canal does not protect from secondary facial paresis in adult acute otitis media
C Meerwein, S Pazahr, T M Stadler, et al.
The Journal of Chemical Physics
|
October 11, 2023
Signature of functional enzyme dynamics in quasielastic neutron scattering spectra: The case of phosphoglycerate kinase
Abir N Hassani, Luman Haris, Markus Appel, et al.
The Journal of Urology
|
February 11, 2003
Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site
Eric C Kauffman, Victoria L Robinson, Walter M Stadler, et al.
Cancer
|
December 18, 2001
Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies
S Mani, N J Vogelzang, D Bertucci, et al.
Thrombosis Research
|
April 27, 2001
Molecular modifications in factor VIII concentrates produced from different plasma pools
E Saenko, D Josic, M Stadler, et al.
The Prostate
|
October 24, 2008
The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer
David Knight, Amy C Peterson, Brian I Rini, et al.
The Journal of Allergy and Clinical Immunology
|
June 1, 1990
A long-term follow-up study of hyposensitization with immunoblotting
E Jarolim, L K Poulsen, B M Stadler, et al.
Page
of 73